The U.S. annual wellness visits market size was exhibited at USD 1.9 billion in 2022 and is projected to hit around USD 5.71 billion by 2032, growing at a CAGR of 11.64% during the forecast period 2023 to 2032.
Key Takeaways:
U.S. Annual Wellness Visits Market Report Scope
Report Coverage | Details |
Market Size in 2023 | USD 2.12 Billion |
Market Size by 2032 | USD 5.71 Billion |
Growth Rate From 2023 to 2032 | CAGR of 11.64% |
Base Year | 2022 |
Forecast Period | 2023 to 2032 |
Segments Covered | Services, type, specialty, provider type |
Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Key Companies Profiled | Morris Hospital & Healthcare Centers; Sparta Community Hospital District; Medical Center Clinic; St. Luke Community Healthcare; Mason Health; UC San Diego; HealthCare Partners, MSO.; Mercy; RUSH Copley Medical Center; Carson Tahoe Health; Overlake Hospital Medical Center; Northwestern Medicine; The General Hospital Corporation; Hamilton Health Care System; UCLA Health |
The growth is attributed to the factors such as increasing focus on preventive care and wellness, strong government support, increasing prevalence of chronic diseases, and the growing aging population. Annual Wellness Visits (AWV)s could help to reduce healthcare costs and improve patient outcomes. For example, one study found that Medicare beneficiaries who received AWV had lower healthcare costs and hospitalization rates than those who did not receive these services. Moreover, AWV can help identify individuals at risk for chronic diseases and provide early interventions, which can lead to improved health outcomes and reduced healthcare costs over time. As a result, there is a growing interest in expanding access to annual wellness visits and making them a standard part of preventive care for individuals of all ages.
The U.S. government has played an important role in supporting annual wellness visits as a tool for preventive care. This has increased access to wellness services for Medicare beneficiaries in the country and has helped to promote the importance of preventive care. In addition, the Affordable Care Act (ACA) requires Medicare to cover certain preventive services, including annual wellness visits, without cost-sharing for patients. This has helped to ensure that individuals with private insurance also have access to these visits.
Mental health conditions, such as depression and anxiety, are prevalent in the U.S. population and can have a significant impact on an individual's overall health and well-being. According to the statistics published by the CDC, more than 50% of the U.S. population would be diagnosed with a mental disorder or illness at some point in their life. Incorporating mental health screenings into annual wellness visits can help identify individuals who may be at risk for these conditions and provide early interventions.
Services Insights
Health risk assessment (HRA) dominated the market in 2022. It is an important component of annual wellness visits . It identifies potential health risks and provides personalized guidance to the patients. Primary care providers can help their patients maintain good health and prevent disease. HRA can also serve as a starting point for ongoing healthcare management and disease prevention.
The cancer screening segment is projected to witness considerable growth in the coming years. Annual wellness visits could help to detect cancer at an early stage when it is more treatable. During the visit, the healthcare provider recommends various cancer screening tests such as pap smears, ultrasounds, and others depending on age, gender, and other risk factors. The identification of risk factors and undiagnosed conditions provides adults with evidence-based preventive care. Owing to these factors the visit has progressively increased.
Type Insights
Subsequent annual wellness visits captured the highest revenue share in 2022. The segment is estimated to dominate the market throughout the forecast period. It helps in healthcare management and assists clinicians evaluate a patient's health status from time to time. Moreover, it identifies any changes or new health risks that may have developed since the previous AWV. Subsequent AWVs also serve as an opportunity to monitor chronic conditions and adjust treatment plans as needed.
The initial AWV segment is projected to witness lucrative growth in the coming years. It is provided to patients who are newly enrolled in Medicare. The exam includes a review of the patient's medical history, current medications, and any existing health conditions. Primary care providers may also conduct screenings for various health issues, such as blood pressure and cholesterol levels among others.
Provider Type Insights
In terms of provider type, the hospitals segment accounted for a major portion of the market. Hospitals conduct annual wellness visits as part of their preventive care services. These visits assist patients to stay healthy and determine any potential health problems at an early stage.Additionally, healthcare providers offer health screenings and tests, such as blood pressure and cholesterol checks, to detect any potential health issues. By conducting annual wellness visits, hospitals can help patients better manage their health and prevent serious illnesses from developing or progressing.
Clinics are projected to witness the fastest growth during the forecast period. The high growth of the segment can be attributed to the favoring reimbursement policies and increasing adoption of AWV. Outpatient clinics are more convenient owing to less waiting time. Moreover, with the deployment of telemedicine in many clinics, access to primary care has increased. This is propelling the segment’s growth.
Specialty Insights
The primary care segment dominated the market in 2022 with a revenue share of 61.9%. The provider recommends lifestyle modifications such as diet and exercise, as well as medications or other treatments to help manage existing health conditions. They can also coordinate follow-up care and referrals to specialists as needed.
The cardiology segment is projected to witness considerable growth during the forecast period. Cardiovascular disease is the leading cause of death in the U.S. and the government is taking several initiatives to prevent disease onset and cardiac events. For instance, cardiovascular risk assessments and screenings are covered by Medicare at no out-of-pocket expense to the patient. These factors are likely to boost the growth of the cardiology segment during the forecast period.
Some of the prominent players in the U.S. Annual Wellness Visits Market include:
Segments Covered in the Report
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor, Inc. has segmented the U.S. Annual Wellness Visits market.
By Type
By Services
By Provider Type
By Specialty
Chapter 1 Report Scope and Objectives
1.1 Market Segmentation
1.2 Regional Scope
1.3 Estimates and Forecast Timeline
1.4 Research Objectives
1.4.1 Objective - 1
1.4.2 Objective - 2
1.4.3 Objective - 3
Chapter 2 Methodology
2.1 Research Methodology
2.2 Information Procurement
2.2.1 Purchased Database
2.2.2 Nova one advisor’s Internal Database
2.2.3 Secondary Sources
2.2.4 Primary Research
2.2.5 Details of Primary Research
2.3 Information or Data Analysis
2.3.1 Data Analysis Models
2.4 Market Formulation & Validation
2.5 Model Details
2.5.1 Volume Price Analysis
2.6 List of Secondary Sources
2.7 List of Abbreviations
Chapter 3 Executive Summary
3.1 Market Outlook
3.1.1 Segment Outlook
3.1.2 Competitive Scenario
3.2 Market Snapshot
3.3 Market Segmentation
3.4 Competitive Landscape
Chapter 4 Market Variables, Trends & Scope
4.1 Market Lineage outlook
4.1.1 Parent market outlook
4.1.2 Ancillary/related market outlook
4.2 Market Dynamics
4.2.1 Market driver analysis
4.2.2 Market restraint analysis
4.3 Business Environment Analysis Tools
4.3.1 Porter’s five forces analysis
4.3.1.1 Competitive rivalry
4.3.1.2 Threat of new entrants
4.3.1.3 Bargaining power of buyers
4.3.1.4 Bargaining power of suppliers
4.3.1.5 Threat of substitutes
4.3.2 PESTEL Analysis
4.3.2.1 Political landscape
4.3.2.2 Economic and social landscape
4.3.2.3 Technological landscape
4.4 Impact of COVID-19: Qualitative Analysis
Chapter 5 U.S. Annual Wellness Visit Market: Type Analysis
5.1 U.S. Annual Wellness Visit Type Market Share Analysis, 2023 & 2032
5.2 U.S. Annual Wellness Visit Type Market: Segment Dashboard
5.3 Market Size & Forecasts and Trend Analyses, 2020 to 2032 for the Type Segment
5.3.1 Initial Annual Wellness Visit
5.3.1.1 Initial annual wellness visit market, 2020 - 2032
5.3.2 Subsequent Annual Wellness Visit
5.3.2.1 Subsequent annual wellness visit market, 2020 - 2032
Chapter 6 U.S. Annual Wellness Visit Market: Services Analysis
6.1 U.S. Annual Wellness Visit Services Market Share Analysis, 2023 & 2032
6.2 U.S. Annual Wellness Visit Services Market: Segment Dashboard
6.3 Market Size & Forecasts and Trend Analyses, 2020 to 2032 for the Application Segment
6.3.1 Health Risk Assessment
6.3.1.1 Health risk assessment market, 2020 - 2032
6.3.2 Physical Exam
6.3.2.1 Physical exam market, 2020 - 2032
6.3.3 Laboratory Tests
6.3.3.1 Laboratory tests market, 2020 - 2032
6.3.4 Immunizations
6.3.4.1 Immunizations market, 2020 - 2032
6.3.5 Cancer Screening
6.3.5.1 Cancer Screening market, 2020 - 2032
6.3.6 Mental Health Screening
6.3.6.1 Mental health screening market, 2020 - 2032
6.3.6 Health Education and Guidance
6.3.6.1 Health education and guidance market, 2020 - 2032
Chapter 7 U.S. Annual Wellness Visit Market: Specialty Analysis
7.1 U.S. Annual Wellness Visit Specialty Market Share Analysis, 2023 & 2032
7.2 U.S. Annual Wellness Visit Specialty Market: Segment Dashboard
7.3 Market Size & Forecasts and Trend Analyses, 2020 to 2032 for the Specialty
7.3.1 Primary care
7.3.1.1 Primary care market, 2020 - 2032
7.3.2 Cardiology
7.3.2.1 Cardiology market, 2020 - 2032
7.3.3 Infectious Diseases
7.3.3.1 Infectious diseases market, 2020 - 2032
7.3.4 Nephrology
7.3.4.1 Nephrology market, 2020 - 2032
7.3.4 Endocrinology
7.3.4.1 Endocrinology market, 2020 - 2032
Chapter 8 U.S. Annual Wellness Visit Market: Provider Type Analysis
8.1 U.S. Annual Wellness Visit Provider Type Market Share Analysis, 2023 & 2032
8.2 U.S. Annual Wellness Visit Provider Type Market: Segment Dashboard
8.3 Market Size & Forecasts and Trend Analyses, 2020 to 2032 for the Provider Type
8.3.1 Clinics
8.3.1.1 Clinics market, 2020 - 2032
8.3.2 Hospitals
8.3.2.1 Hospitals market, 2020 - 2032
8.3.3 Physician's Office
8.3.3.1 Physician's offices market, 2020 - 2032
Chapter 9 Competitive Analysis
9.1 Company Categorization
9.2 Company Market Position Analysis
9.3 Strategy Mapping
9.4 Company Profiles/ Listing
9.4.1 Morris Hospital & Healthcare Centers
9.4.1.1 Ccliniompany overview
9.4.1.2 Financial performance
9.4.1.3 Product benchmarking
9.4.1.4 Strategic initiatives
9.4.2 Sparta Community Hospital District
9.4.2.1 Company overview
9.4.2.2 Financial performance
9.4.2.3 Product benchmarking
9.4.2.4 Strategic initiatives
9.4.3 Medical Center Clinic
9.4.3.1 Company overview
9.4.3.2 Financial performance
9.4.3.3 Product benchmarking
9.4.3.4 Strategic initiatives
9.4.4 St. Luke Community Healthcare
9.4.4.1 Company overview
9.4.4.2 Financial performance
9.4.4.3 Product benchmarking
9.4.4.4 Strategic initiatives
9.4.5 Mason Health
9.4.5.1 Company overview
9.4.5.2 Financial performance
9.4.5.3 Product benchmarking
9.4.5.4 Strategic initiatives
9.4.6 UC San Diego
9.4.6.1 Company overview
9.4.6.2 Financial performance
9.4.6.3 Product benchmarking
9.4.6.4 Strategic initiatives
9.4.7 HealthCare Partners, MSO.
9.4.7.1 Company overview
9.4.7.2 Financial performance
9.4.7.3 Product benchmarking
9.4.7.4 Strategic initiatives
9.4.8 Mercy
9.4.8.1 Company overview
9.4.8.2 Financial performance
9.4.8.3 Product benchmarking
9.4.8.4 Strategic initiatives
9.4.9 RUSH Copley Medical Center
9.4.9.1 Company overview
9.4.9.2 Financial performance
9.4.9.3 Product benchmarking
9.4.9.4 Strategic initiatives
9.4.10 Carson Tahoe Health
9.4.10.1 Company overview
9.4.10.2 Financial performance
9.4.10.3 Product benchmarking
9.4.10.4 Strategic initiatives
9.4.11 Overlake Hospital Medical Center
9.4.11.1 Company overview
9.4.11.2 Financial performance
9.4.11.3 Product benchmarking
9.4.11.4 Strategic initiatives
9.4.12 Northwestern Medicine
9.4.12.1 Company overview
9.4.12.2 Financial performance
9.4.12.3 Product benchmarking
9.4.12.4 Strategic initiatives
9.4.13 The General Hospital Corporation
9.4.13.1 Company overview
9.4.13.2 Financial performance
9.4.13.3 Product benchmarking
9.4.13.4 Strategic initiatives
9.4.14 Hamilton Health Care System
9.4.14.1 Company overview
9.4.14.2 Financial performance
9.4.14.3 Product benchmarking
9.4.14.4 Strategic initiatives
9.4.15 UCLA Health
9.4.15.1 Company overview
9.4.15.2 Financial performance
9.4.15.3 Product benchmarking
9.4.15.4 Strategic initiatives